US to allow states to distribute Gilead’s remdesivir drug to fight COVID-19

US to allow states to distribute Gilead's remdesivir drug to fight COVID-19

(STL.News) The U.S. Department of Health and Human Services (HHS) said on Saturday it would allow state health departments to distribute Gilead Sciences Inc‘s remdesivir drug to fight COVID-19, and the United States would receive about 40% of the drug maker’s global donation.  Read HHS article on STL.News.

YouTube video courtesy of WION News

About Marty Smith 10908 Articles
Marty Smith is the Editor in Chief and a founder of STL.News, DirectSourceNews.org, and St. Louis Restaurant Review. As Editor in Chief, Smith is responsible for the content posted on the network with the help of the publishing team, which is located around the globe. Additionally, Smith is responsible for building a network of aggregator sites to manage the content involving thousands of sources.